Clinical Data Scientist Intern at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Currently enrolled in a Master’s program for Data Science, Analytics, Bioinformatics, Informatics, Mathematics, Statistics, or other relevant Technical Science with an expected graduation date of Dec. 2026 – May 2027
Proficient in R or Python programming
Experience in implementing ML algorithms
Proven ability to work creatively and analytically in a problem-solving environment
Exposure to dashboard development in PowerBI or Tableau
Demonstrated teamwork and collaboration on diverse teams
In-depth understanding of programming, logic, data flow, and database architecture

Responsibilities

Develop an understanding of processes and procedures within the Data and Analytics business unit
Drive real time analytics to enable full value realization of emerging data collection modalities
Ensure system validation and reliability
Develops and tests new ideas and/or applies innovative solutions that create value
Contribute to ongoing analytics initiatives or help lay the foundation for new initiatives within the Data and Analytics organization
Work on project opportunities in areas such as cloud computing, machine learning, process automation, database development, or dashboard design and development
Present project highlights, findings, and general accomplishments to Clinical Data Sciences professionals at the conclusion of the work period

Skills

Machine Learning

Cloud Computing

Process Automation

Database Development

Dashboard Design

Programming

Data Analytics

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free